ReviewTherapeutic advances in neurological disorders2018

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.

Thomas G Forsthuber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.